Tissue And Organ Transplantation Market
Tissue and organ transplantation involves replacing damaged or diseased body parts with healthy tissues and organs from donors. Organs like kidney, heart, liver, lungs and pancreas as well as corneas, middle ear, heart valves, skin and bones can be replaced through transplantation. Transplantation enhances the quality of life by restoring impaired organ functions.
The global Tissue And Organ Transplantation Market is estimated to be valued at Us$ 20.8 Bn in 2023 and is expected to exhibit a CAGR Of 7.9% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
The one key trend accelerating growth in the tissue and organ transplantation market is increased organ donation. There is a widening gap between the number of patients requiring organ transplantation and actual organ donations. According to data, over 114,000 patients were on the organ transplant waiting list in 2021 globally. However, only around 40,000 transplants were performed. This disparity has led health organizations across countries to focus on public education programs to promote organ donation programs and registration. In recent years, innovative schemes such as organ donation benefits for donors and their families as well as presumed consent have increased organ donations rates in certain regions. This is projected to bolster the growth of the tissue and organ transplantation market during the forecast period.
Segment Analysis
The global tissue and organ transplantation market is segmented on the basis of tissue type, organ type, end-user, and geography. Based on tissue type, the kidney segment dominated the market in 2020. Kidneys occupy a major share due to increasing cases of kidney failures as well as increase in awareness regarding organ and tissue donation. Kidneys have always been a majorly transplanted organ and account for majority of transplant procedures globally.
Key Takeaways
The
Global Tissue And Organ Transplantation Market Demand is expected to witness high growth over the forecast period of 2024 to 2031. The global tissue and organ transplantation market is estimated to be valued at US$ 20.8 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2031.
Regional Analysis :
The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. This is attributed to the heavy burden of chronic kidney disease and improving healthcare infrastructure in this region.
Key players operating in the tissue and organ transplantation market are Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), UAS Laboratories LLC.
Get more insights on this topic :
https://www.insightprobing.com/the-rising-demand-for-organ-donation-is-driving-the-tissue-and-organ-transplantation-market/
Check more trending articles on this topic:
https://ceocolumn.com/health/bisphenol-a-odyssey-navigating-the-controversial-waters-of-this-ubiquitous-chemical-compound/
Comments
Post a Comment